Latest filing published 03 Jan 2008 for Elite Pharmaceuticals INC, €3,561.
Insider track record
No signal scores available.
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -95.3%Entry US$1.70 · Close at T+365 US$0.08
- -97.5%Entry US$2.00 · Close at T+365 US$0.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Bernard Berk: trading record in brief
This profile gathers the share dealings of Bernard Berk in Elite Pharmaceuticals Inc. In total, 8 filings cover trades dated from 20 November 2007 to 31 December 2007.
On the market, this insider has only ever bought: 8 purchases, €39k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2008 alone, the filings show 2 purchases and no sales.
The median purchase comes to €4,435. Looking at 8 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -45.0%. Past outcomes like these are no guarantee of what comes next.
On 3 January 2008 came the latest disclosure, an open-market purchase for €3,561 in Elite Pharmaceuticals Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bernard Berk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$2.08Common StockSEC:0000930413-08-000036:0Canonical exit: 30 Mar 2008 (T+90)
- 2,500 shares@ US$2.05Common StockSEC:0000930413-08-000036:1Canonical exit: 30 Mar 2008 (T+90)
- 1,500 shares@ US$2.06Common StockSEC:0000930413-07-008951:0Canonical exit: 18 Feb 2008 (T+90)
- 3,500 shares@ US$2.25Common StockSEC:0000930413-07-008951:1Canonical exit: 18 Feb 2008 (T+90)
- 5,000 shares@ US$2.25Common StockSEC:0000930413-07-008951:2Canonical exit: 18 Feb 2008 (T+90)
- 2,500 shares@ US$2.04Common StockSEC:0000930413-07-008951:3Canonical exit: 19 Feb 2008 (T+90)
- 5,000 shares@ US$2.02Common StockSEC:0000930413-07-008951:4Canonical exit: 19 Feb 2008 (T+90)
- 5,000 shares@ US$2.04Common StockSEC:0000930413-07-008951:5Canonical exit: 19 Feb 2008 (T+90)
8 of 8 declarations